Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Usana Health SciencesUSNA +0.23%66 Median PS Value is $74.10 as of Jul. 14, 2026, which is 7783% above its 10-year median of 0.94. GuruFocus rates USNA with a GF Score™ of 66/100 and a GF Value™ of $41.41 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 1,137 Consumer Packaged Goods companies, Usana Health Sciences ranks better than 94.64% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Usana Health Sciences's Median PS Value or its related term are showing as below:
USNA'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.24 Med: 0.94 Max: 1.78
Current: 0.3
During the past 13 years, the highest Price to Median PS Value of Usana Health Sciences was 1.78. The lowest was 0.24. And the median was 0.94.
USNA's Price-to-Median-PS-Value is ranked better than 94.64% of 1137
companies
in the Consumer Packaged Goods industry
Industry Median: 0.84
vs USNA: 0.30
Usana Health Sciences (NYSE:USNA) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Usana Health Sciences's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
22.03
/
74.10
=
0.30
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Usana Health Sciences Median PS Value Related Terms
Usana Health Sciences Median PS Value Historical Data
* Premium members only.
The historical data trend for Usana Health Sciences's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
USNA vs NATR, ENHA, BYND: Median PS Value Comparison
For the Packaged Foods subindustry, Usana Health Sciences's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Usana Health Sciences Price-to-Median-PS-Value vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Usana Health Sciences's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Usana Health Sciences's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 1.4713.
Usana Health Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $50.365.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Usana Health Sciences (USNA) has a Median PS Value of $74.10 as of Jul. 14, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Usana Health Sciences and its competitors. This is 7783% above median its historical median of 0.94. Over the past decade, Usana Health Sciences' Median PS Value has ranged from 0.24 to 1.78. According to the industry distribution chart, Usana Health Sciences ranks #61 out of 1137 companies in the Consumer Packaged Goods industry, placing it in the top 5.4%.
Is Usana Health Sciences' Median PS Value too high?
Usana Health Sciences' current Median PS Value of $74.10 is 7783% above median its 10-year median of 0.94. Over the past 10 years, this metric has ranged from a low of 0.24 to a high of 1.78. The Consumer Packaged Goods industry median Median PS Value is 0.84. Usana Health Sciences' value of $74.10 is 8721.4% above this industry median. Based on the distribution chart, Usana Health Sciences ranks #61 out of 1137 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Usana Health Sciences has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Usana Health Sciences' Median PS Value compare to NATR and ENHA?
According to the Consumer Packaged Goods industry distribution chart, Usana Health Sciences ranks #61 out of 1137 companies for Median PS Value. This places Usana Health Sciences in the top 5% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.84. Usana Health Sciences' value of $74.10 is 8721.4% above this benchmark. Historically, Usana Health Sciences' own Median PS Value has ranged from 0.24 to 1.78 over the past decade. While the company's 10-year median is 0.94 vs. the industry median of 0.84, Usana Health Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Consumer Packaged Goods company?
The median Median PS Value among Consumer Packaged Goods companies is 0.84, based on 1,137 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Usana Health Sciences's current Median PS Value of $74.10 is 8721.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Usana Health Sciences and its competitors. For the Consumer Packaged Goods industry, the median Median PS Value is 0.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Usana Health Sciences's current Median PS Value is $74.10, which is 7783% above median its own 10-year median of 0.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Usana Health Sciences stock overvalued right now?
Based on GuruFocus' analysis, Usana Health Sciences (USNA) is currently considered Possible Value Trap. The stock's GF Value™ is $41.41, compared to a current price of $22.03 — trading 46.8% below its estimated fair value. The current Median PS Value is $74.10, which is 7783% above median its 10-year median of 0.94 and 8721.4% above the Consumer Packaged Goods industry median of 0.84. Usana Health Sciences' overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Usana Health Sciences (USNA), the current Median PS Value is $74.10 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Usana Health Sciences (USNA) Overvalued in 2026?
Based on GuruFocus' analysis, Usana Health Sciences stock appears to be undervalued.
The current stock price of $22.03 is trading 46.8% below its estimated GF Value™ of $41.41.
GuruFocus considers Usana Health Sciences to be Possible Value Trap.
Key valuation signals for USNA:
Median PS Value: $74.10 (7783% above median its 10-year median of 0.94)
GF Value™: $41.41 vs. price of $22.03 (46.8% below fair value)
Industry Position: 8721.4% above the Consumer Packaged Goods median (#61 of 1137)
No single metric tells the full story. See the USNA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
66GF Score
Get the complete analysis for USNA
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
USNA has been successfully added to your 
